Browse > Article
http://dx.doi.org/10.5483/BMBRep.2015.48.1.125

Amyloid pore-channel hypothesis: effect of ethanol on aggregation state using frog oocytes for an Alzheimer's disease study  

Parodi, Jorge (Laboratorio de Fisiologia de la Reproduccion, Nucleo de Investigacionen Produccion Alimentaria, Facultad de Recursos Naturales, Escuela de Medicina Veterinaria, Universidad Catolica de Temuco)
Ormeno, David (Laboratorio de Fisiologia de la Reproduccion, Nucleo de Investigacionen Produccion Alimentaria, Facultad de Recursos Naturales, Escuela de Medicina Veterinaria, Universidad Catolica de Temuco)
Paz, Lenin D. Ochoa-de la (Laboratorio de Fisiologia Celular, Departamento de Bioquimica, Facultad de Medicina, Universidad Nacional Autonoma de Mexico, Ciudad Universitaria)
Publication Information
BMB Reports / v.48, no.1, 2015 , pp. 13-18 More about this Journal
Abstract
Alzheimer's disease severely compromises cognitive function. One of the mechanisms to explain the pathology of Alzheimer's disease has been the hypotheses of amyloid-pore/channel formation by complex $A{\beta}$-aggregates. Clinical studies suggested the moderate alcohol consumption can reduces probability developing neurodegenerative pathologies. A recent report explored the ability of ethanol to disrupt the generation of complex $A{\beta}$ in vitro and reduce the toxicity in two cell lines. Molecular dynamics simulations were applied to understand how ethanol blocks the aggregation of amyloid. On the other hand, the in silico modeling showed ethanol effect over the dynamics assembling for complex $A{\beta}$-aggregates mediated by break the hydrosaline bridges between Asp 23 and Lys 28, was are key element for amyloid dimerization. The amyloid pore/ channel hypothesis has been explored only in neuronal models, however recently experiments suggested the frog oocytes such an excellent model to explore the mechanism of the amyloid pore/channel hypothesis. So, the used of frog oocytes to explored the mechanism of amyloid aggregates is new, mainly for amyloid/pore hypothesis. Therefore, this experimental model is a powerful tool to explore the mechanism implicates in the Alzheimer's disease pathology and also suggests a model to prevent the Alzheimer's disease pathology.
Keywords
Amyloid; Channel; Ethanol; Oocytes; Pore;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Sun AY, Simonyi A and Sun GY (2002) The "French Paradox" and beyond: neuroprotective effects of polyphenols. Free Radic Biol Med 32, 314-318   DOI   ScienceOn
2 Ding F, LaRocque JJ and Dokholyan NV (2005) Direct observation of protein folding, aggregation, and a prion-like conformational conversion. J Biol Chem 280, 40235-40240   DOI   ScienceOn
3 Lührs T, Ritter C, Adrian M (2005) 3D structure of Alzheimer's amyloid-beta(1-42) fibrils. Proc Natl Acad Sci U S A 102, 17342-17347   DOI   ScienceOn
4 Edelstein-keshet L and Spiros A (2002) Exploring the formation of Alzheimer's disease senile plaques in silico. J Theor Biol 216, 301-326   DOI   ScienceOn
5 Orgogozo JM, Dartigues JF, Lafont S et al (1997) Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev Neurol (Paris) 153, 185-192
6 Ho L, Chen LH, Wang J et al (2009) Heterogeneity in red wine polyphenolic contents differentially influences Alzheimer's disease-type neuropathology and cognitive deterioration. J Alzheimers Dis 16, 59-72   DOI
7 Scarmeas N, Luchsinger JA, Mayeux R and Stern Y (2007) Mediterranean diet and Alzheimer disease mortality. Neurology 69, 1084-1093   DOI   ScienceOn
8 Zhao J, Wang Q, Liang G and Zheng J (2011) Molecular Dynamics Simulations of Low-Ordered Alzheimer beta-Amyloid Oligomers from Dimer to Hexamer on Self-Assembled Monolayers. Langmuir 27, 14876-14887   DOI
9 Ormeno D, Romero F, Lopez-Fenner J, Avila A, Martinez-Torres A and Parodi J (2013) Ethanol reduces amyloid aggregation in vitro and prevents toxicity in cell lines. Arch Med Res 44, 1-7   DOI   ScienceOn
10 Russo A, Palumbo M, Aliano C, Lempereur L, Scoto G and Renis M (2003) Red wine micronutrients as protective agents in Alzheimer-like induced insult. Life Sci 72, 2369-2379   DOI   ScienceOn
11 Wang J, Ho L, Zhao Z et al (2006) Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease. FASEB J 20, 2313-2320   DOI   ScienceOn
12 Noor H, Cao P and Raleigh DP (2012) Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibers. Protein Sci 21, 373- 382   DOI
13 Cornejo A, Jimenez JM, Caballero L, Melo F and Maccioni RB (2011) Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease. J Alzheimers Dis 27, 143-153
14 Collins MA, Neafsey EJ, Wang K, Achille NJ, Mitchell RM and Sivaswamy S (2010) Moderate ethanol preconditioning of rat brain cultures engenders neuroprotection against dementia-inducing neuroinflammatory proteins: possible signaling mechanisms. Mol Neurobiol 41, 420-425   DOI   ScienceOn
15 Kang IJ, Jeon YE, Yin XF et al (2011) Butanol extract of Ecklonia cava prevents production and aggregation of beta-amyloid, and reduces beta-amyloid mediated neuronal death. Food Chem Toxicol 49, 2252-2259   DOI   ScienceOn
16 Yevenes GE, Peoples RW, Tapia JC et al (2003) Modulation of glycine-activated ion channel function by G-protein betagamma subunits. Nat Neurosci 6, 819-824   DOI   ScienceOn
17 Gundersen CB, Jenden DJ and Miledi R (1985) Choline acetyltransferase and acetylcholine in Xenopus oocytes injected with mRNA from the electric lobe of Torpedo. Proc Natl Acad Sci U S A 82, 608-611   DOI   ScienceOn
18 Bernareggi A, Duenas Z, Reyes-Ruiz JM, Ruzzier F and Miledi R (2007) Properties of glutamate receptors of Alzheimer's disease brain transplanted to frog oocytes. Proc Natl Acad Sci U S A 104, 2956-2960   DOI   ScienceOn
19 Miledi R, Duenas Z, Martinez-Torres A, Kawas CH and Eusebi F (2004) Microtransplantation of functional receptors and channels from the Alzheimer's brain to frog oocytes. Proc Natl Acad Sci U S A 101, 1760-1763   DOI   ScienceOn
20 Demuro A, Mina E, Kayed R, Milton SC, Parker I and Glabe CG (2005) Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers. J Biol Chem 280, 17294- 17300   DOI   ScienceOn
21 Parodi J, Ochoa-de la Paz L, Miledi R and Martinez-Torres A (2012) Functional and structural effects of amyloid-beta aggregate on Xenopus laevis oocytes. Mol Cells 34, 349-355   DOI
22 Demuro A and Parker I (2013) Cytotoxicity of intracellular abeta42 amyloid oligomers involves Ca2+ release from the endoplasmic reticulum by stimulated production of inositol trisphosphate. J Neurosci 33, 3824-3833   DOI   ScienceOn
23 Demuro A, Smith M and Parker I (2011) Single-channel Ca(2+) imaging implicates Abeta1-42 amyloid pores in Alzheimer's disease pathology. J Cell Biol 195, 515-524   DOI   ScienceOn
24 Peters R, Peters J, Warner J, Beckett N and Bulpitt C (2008) Alcohol, dementia and cognitive decline in the elderly: a systematic review. Age Ageing 37, 505-512   DOI   ScienceOn
25 Anstey KJ, Mack HA and Cherbuin N (2009) Alcohol consumption as a risk factor for dementia and cognitive decline: meta-analysis of prospective studies. Am J Geriatr Psychiatry 17, 542-555   DOI   ScienceOn
26 Alarcon JM, Brito JA, Hermosilla T, Atwater I, Mears D and Rojas E (2006) Ion channel formation by Alzheimer's disease amyloid beta-peptide (Abeta40) in unilamellar liposomes is determined by anionic phospholipids. Peptides 27, 95-104   DOI   ScienceOn
27 Bush AI, Pettingell WH, Multhaup G et al (1994) Rapid induction of Alzheimer A beta amyloid formation by zinc. Science 265, 1464-1467   DOI   ScienceOn
28 Kourie JI, Henry CL and Farrelly P (2001) Diversity of amyloid beta protein fragment [1-40]-formed channels. Cell Mol Neurobiol 21, 255-284   DOI   ScienceOn
29 Glabe CG and Kayed R (2005) Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology 66(2 Suppl 1), S74-78
30 Mosa KA, Kumar K, Chhikara S et al (2012) Members of rice plasma membrane intrinsic proteins subfamily are involved in arsenite permeability and tolerance in plants. Transgenic Res 21, 1265-1277   DOI   ScienceOn
31 Wood WG, Schroeder F, Igbavboa U, Avdulov NA and Chochina SV (2002) Brain membrane cholesterol domains, aging and amyloid beta-peptides. Neurobiol Aging 23, 685-694   DOI   ScienceOn
32 Simakova O and Arispe NJ (2007) The cell-selective neurotoxicity of the Alzheimer's Abeta peptide is determined by surface phosphatidylserine and cytosolic ATP levels. Membrane binding is required for Abeta toxicity. J Neurosci 27, 13719-13729   DOI   ScienceOn
33 Morrill GA and Kostellow AB (1998) Progesterone release of lipid second messengers at the amphibian oocyte plasma membrane: role of ceramide in initiating the G2/M transition. Biochem Biophys Res Commun 246, 359-363   DOI   ScienceOn
34 Schmidt D and MacKinnon R (2008) Voltage-dependent K+ channel gating and voltage sensor toxin sensitivity depend on the mechanical state of the lipid membrane. Proc Natl Acad Sci U S A 105, 19276-19281   DOI   ScienceOn
35 Mattson MP and Chan SL (2001) Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits. J Mol Neurosci 17, 205-224   DOI   ScienceOn
36 Jang H, Zheng J and Nussinov R (2007) Models of beta-amyloid ion channels in the membrane suggest that channel formation in the bilayer is a dynamic process. Biophys J 93, 1938-1949   DOI   ScienceOn
37 Arispe N, Diaz JC and Simakova O (2007) Abeta ion channels. Prospects for treating Alzheimer's disease with Abeta channel blockers. Biochim Biophys Acta 1768, 1952-1965   DOI   ScienceOn
38 Kawahara M, Arispe N, Kuroda Y and Rojas E (1997) Alzheimer's disease amyloid beta-protein forms Zn(2+)-sensitive, cation-selective channels across excised membrane patches from hypothalamic neurons. Biophys J 73, 67-75   DOI   ScienceOn
39 Prangkio P, Yusko EC, Sept D, Yang J and Mayer M (2012) Multivariate analyses of amyloid-beta oligomer populations indicate a connection between pore formation and cytotoxicity. PLoS One 7, e47261   DOI
40 Mattson MP (2004) Pathways towards and away from Alzheimer's disease. Nature 430, 631-639   DOI   ScienceOn
41 Arispe N (2004) Architecture of the Alzheimer's A beta P ion channel pore. J Membr Biol 197, 33-48   DOI
42 Connelly L, Jang H, Arce FT et al (2012) Atomic force microscopy and MD simulations reveal pore-like structures of all-D-enantiomer of Alzheimer's beta-amyloid peptide: relevance to the ion channel mechanism of AD pathology. J Phys Chem B 116, 1728-1735   DOI   ScienceOn
43 Stockl MT, Zijlstra N and Subramaniam V (2013) alpha-Synuclein oligomers: an amyloid pore? Insights into mechanisms of alpha-synuclein oligomer-lipid interactions. Mol Neurobiol 47, 613-621   DOI   ScienceOn
44 Uetsuki T, Takemoto K, Nishimura I et al (1999) Activation of neuronal caspase-3 by intracellular accumulation of wild-type Alzheimer amyloid precursor protein. J Neurosci 19, 6955-6964
45 Kim DS, Kim JY and Han YS (2007) Alzheimer's disease drug discovery from herbs: neuroprotectivity from beta-amyloid (1-42) insult. J Altern Complement Med 13, 333-340   DOI
46 Sepulveda FJ, Parodi J, Peoples RW, Opazo C and Aguayo LG (2010) Synaptotoxicity of Alzheimer beta amyloid can be explained by its membrane perforating property. PLoS One 5, e11820   DOI   ScienceOn
47 Clark EM and Vulliet R (1993) Toxicity of beta-amyloid25-35 peptide in PC12 cells. Proc West Pharmacol Soc 36, 273-276
48 Wang L, Colodner KJ and Feany MB (2011) Protein misfolding and oxidative stress promote glial-mediated neurodegeneration in an Alexander disease model. J Neurosci 31, 2868-2877   DOI   ScienceOn
49 Kawahara M, Kuroda Y, Arispe N and Rojas E (2000) Alzheimer's beta-amyloid, human islet amylin, and prion protein fragment evoke intracellular free calcium elevations by a common mechanism in a hypothalamic GnRH neuronal cell line. J Biol Chem 275, 14077-14083   DOI   ScienceOn
50 Quist A, Doudevski I, Lin H et al (2005) Amyloid ion channels: a common structural link for protein-misfolding disease. Proc Natl Acad Sci U S A 102, 10427- 10432   DOI   ScienceOn
51 Sepúlveda FJ, Fierro H, Fernandez E et al (2014) Nature of the neurotoxic membrane actions of amyloid-beta on hippocampal neurons in Alzheimer's disease. Neurobiol Aging 35, 472-481   DOI   ScienceOn
52 Arispe N, Pollard HB and Rojas E (1994) The ability of amyloid beta-protein [A beta P (1-40)] to form Ca2+ channels provides a mechanism for neuronal death in Alzheimer's disease. Ann N Y Acad Sci 747, 256-266   DOI
53 Bourin M, Ripoll N and Dailly E (2003) Nicotinic receptors and Alzheimer's disease. Curr Med Res Opin 19, 169-177   DOI   ScienceOn
54 Rowan MJ, Klyubin I, Wang Q and Anwyl R (2005) Synaptic plasticity disruption by amyloid beta protein: modulation by potential Alzheimer's disease modifying therapies. Biochem Soc Trans 33, 563-567   DOI   ScienceOn
55 Walsh DM, Klyubin I, Fadeeva JV et al (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539   DOI   ScienceOn
56 Bell KF and Claudio Cuello A (2006) Altered synaptic function in Alzheimer's disease. Eur J Pharmacol 545, 11-21   DOI   ScienceOn
57 Yankner BA and Lu T (2009) Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease. J Biol Chem 284, 4755-4759   DOI   ScienceOn
58 Parodi J, Sepulveda FJ, Roa J, Opazo C, Inestrosa NC and Aguayo LG (2010) Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure. J Biol Chem 285, 2506-2514   DOI   ScienceOn
59 Nishimura I, Uetsuki T, Dani SU et al (1998) Degeneration in vivo of rat hippocampal neurons by wild-type Alzheimer amyloid precursor protein overexpressed by adenovirus-mediated gene transfer. J Neurosci 18, 2387-2398
60 Oddo S, Caccamo A, Tran L et al (2006) Temporal profile of amyloid-beta (Abeta) oligomerization in an in vivo model of Alzheimer disease. A link between Abeta and tau pathology. J Biol Chem 281, 1599-1604   DOI   ScienceOn
61 Zhu YJ, Lin H and Lal R (2000) Fresh and nonfibrillar amyloid beta protein (1-40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AbetaPchannel-mediated cellular toxicity. FASEB J 14, 1244-1254   DOI
62 Lacor PN, Buniel MC, Chang L et al (2004) Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J Neurosci 24, 10191-10200   DOI   ScienceOn
63 Uc EY and Rizzo M (2008) Driving and neurodegenerative diseases. Curr Neurol Neurosci Rep 8, 377-383   DOI   ScienceOn
64 Haass C and Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8, 101- 112   DOI   ScienceOn
65 Ziegler-Graham K, Brookmeyer R, Johnson E and Arrighi HM (2008) Worldwide variation in the doubling time of Alzheimer's disease incidence rates. Alzheimers Dement 4, 316-323   DOI   ScienceOn